CRDN

Views & Analysis

Tunnah’s musings: Rare diseases hold key to future of drug d...

The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.

Views & Analysis

Rethinking rare diseases: treat the whole patient

CRDN wants to break down barriers in communication between rare disease patients, HCPs and industry.

R&D

The long-delayed promise of the microbiome, with Sam Possemi...

Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks